ῌ,**. The Japanese Society for AIDS Research
The Journal of AIDS Research
: HAART ῌ
+ . !"#$%&
AIDS !"#$%&'$()*+,
+: @
@OOP€p!"=PH&
HAART "-./012"ῌ34/5
"U$(6, QRa&qCr"‚Jƒ7 „
67 &8"9$'*+: ;7 Sƒ=PH)?@;7 (P…Ta=†6TS7
HIV <" - " + ; AIDS =>?@
HIV <"@UTV$=WX5i^);
/*";A$(67 B>C=
"‡)', „STV"Yˆ7 @‰Z7 Š‹!
DE HIV ;?@F;GHI&
7 ~@C'e)"Œ[=H, [)/q\
J?@, K!""'*#L&
CT7 ]^_`7 `Ž_`7 `,Š[
;7 2<$M%& HIV <'*, N$
=, I'P BAL u TBLB 'e"a&[&b
+331 (OP) - (Q$RSP@T +/0
H, @;‘’@Yˆ7 cd
"# +.1 HIV <$(67 # 0/῍ $
n’P“e“Ž[=”7 C"f=gh
AIDS =/*T,:, Mirza P7 +33, (OP ,*** (
H^);$(,
U$"*NV)WX5Y
,: C
"KZ+[=.T, +.3+ ";RSP@7
# 23῍ ; HIV 2<$(.T ,
-:
Ra&Xiuj$H;7 klu•Wm7
t–"—˜n™7 !>j$&W12"I=X
oi^);š$(,
, K!"#LCp›;q
*TS7 ;œr$(.T67 3&'i
Cryptococcus neoformans "\./]^,
Žs0&œ•WOcžtW"^);(6, 8"TS
C. neoformans C. neoformans var. neoformans _`,a
U“"I=uŸ&‘^)() +
A, D, AD: ) C. neoformans var. gatti _`,a B, C: " / b
, Ž[$vw"G)x"4y7 x¡z—"
"`,a;(^);-P@/567 $.?@&
¢{';0P@";Ra&$(;7
""c)de _3*῍: A a$(,
*^@P"Cp›ŸS/œr'Yˆ&(6|"
K!""
$7 e“}£~\!?"¤)_`[=€H
- ^);$(, C$`,5\¥Ž"
C. neoformans /0'efg1hi./*,
Š; 33῍ ¦‚$ƒ')?@/567
2'e34"51$6/567 78&8@;j
„•&§i…Wz†$(, UTῌy'*
97 :kH^)$l)'6;7 ^@P2"5m
;‡¨©TV=sFH^)&(67 X\ MRI =”
";<))"noKZ&=>?@/*'
Hª«$(,
*.:, !?;#L@ApB?@^)\./]
Metta P /+ " HIV 2<"C
^, qCr$DE=sF@
b*/¬­®¯°±b=*7 `Ž_`$
=H;7
0/.,῍7 Ž_`$ 3..+῍7 Ž"}£~$ 13.+῍ ;ƒ
K!"#L5*/!`=Gt
=HT7 Cu@I7 vwxJ
$(.T)ˆ²/*/:,
yK=HH, C!;1LMz{m"N=|b
-: 8"‰
^)\;7 8"N"}~!>$(,
‘<’“” : ¶+0,῍20// •·–—#¸¹º +῍,+῍+ ῌ
,**. ( + » -+ ¼˜
+0 _ +0 :
"ŠGt"‚³7 ‹Œu´&TV=sF, ‹Œ
TVs&Žy)4µ/567 Œ[=H
,
The Journal of AIDS Research Vol. 0
+
/ HIV 38?@
²,=
!"#$% &'
!"#() *+,-% ./01 234567
[\
RQST
45: +**ῌ% ?@ 2+.2ῌ% ³O
FLCZ ,**ῌ.** mgῌ[% §¨
ITCZ ,**ῌ.** mgῌ[% §¨
FLCZ .** mg ῌ [ ´ /-FC +** ῌ +/*
mgῌkgῌ[ῌ\ . +* …
AII
CII
CII
?45 Gµ1ƒ=
2 DEB18F +**ῌ : G' 33ῌ= H
[\
./RSTῌ&F,UVW
-% XY Z8F:)
0 AMPH-B *.1ῌ+.* mgῌkgῌ[´/-FC
+** mgῌkgῌ[ῌ\ . , …%
¶ & FLCZ .** mgῌ[ +* …DE
RQST AMPH-B *.1ῌ+.* mgῌkgῌ[´/-FC
+** mgῌkgῌ[ῌ\ . 0ῌ+* …
AMPH-B *.1ῌ+.* mgῌkgῌ[ 0ῌ+* …
AI
FLCZ .**ῌ2** mgῌ[ +*ῌ+, …
ITCZ .** mgῌ[ +*ῌ+, …
Lipid mulation of AMPH-B -ῌ0 mgῌ
kgῌ[ 0ῌ+* …
CI
CII
CII
[\]T!^_B" + `8C 1=
+= ?@
#@a:bF$c%&de: HIV f:4
5ghiVj'1,-% &(T!)#)
kl> T!*1 +,mnopqF
-V T! ./45g hi 0r:$% s
1E tuv>w./? 01xT
!2r yz8{+<kl<% |38C
F :)
,= ?45
T!XYm}~ 45)-2= B€kV
W: ‚ƒT!8 AMPH-B *.1 mg ῌ kg ῌ day
67 Gn„,*,= /-FC
8 Gn„+13= : , …†
T! GZ± 1= >$
T!^_
?@ 2+.2ῌ :$% 4ABC23 ) bD NO?EP8) :Q:
,**.
?@
869: ;<0= >./ % ?@:- IJ1KL@ M
No. +
45&
BI
CI
£UT!
[\
FLCZ ,**ῌ.** mgῌ[% §¨
RQST ITCZ ,** mgῌ[% §¨
AMPH-B + mg/kg +ῌ- times/week,
§¨
AI
BI
CI
*FLCZ : Fluconazole, ITCZ : Itraconazole, AMPH-B : Amphotericin B, /-FC : Flucytosine
*AMPH-B Lipid formulation ] ^ · : ¸ ¨ _ ` ¹
AIDS T!Cº»a http : //www.iijnet.or.jp/aidsdrugmhwῌ:b
¼j'
T!8C% - 2 …†B FLCZ .** mgῌday Gn„+/+=
ITCZ .** mg Gn„+//= :T!84A L01
VW`]% - FG—@
x9v>wSXYm-8C , …†. 4AL
E@῍ ]˜% CHI™š JKˆ<% @ H
01x9 /-FC 8‡,ˆbC G0*ῌ vs /+ῌ, p„
–D0B[\8) LM N›f% *.*0= +* …. 4AL01x9 FLCZ 1,ῌ, ITCZ 0*ῌ
cœ?@ ῍,O Gž
:Q,ˆbC NO‰†:SXY"
)9= Ÿ V23)9¡)238ˆ)#)
:+<)ˆbC &;8 Š<9}‚
kl< CD. /* ῌ mL D
, …†:
/./ῌ% - 2 …†: -.3ῌ :bC
T!*(: AMPH-B
4‹=>?Fkl<
:H@:) AŒ4ABŽ84AB
+**ῌ,** mgῌday
@(BP¢ FLCZ
>?B-V
,= Q–D0 G£UT!=
45T!& f% ¤ED0 C+&(£UT
]‘C% *.+ mgῌ*.,/ mgῌ- mL B’8CC“B
! )#) FLCZ
4‹=>?V WB… ,ῌ- ”i•
:£UT!§¨Vb©]W[\]
1 += H–D0
CD. >?RHST:$% ¥¦U
FLCZ WX1,-% .** mgῌday
6ª9
Yƒ>?:F
@(JK#->?B©: H%
HAART >b CD. ,)bCf:% £UT!
fKL“B>?VW:E@῍
B2r8F¤E«<)•¬­®¯°
+1
G +1 =
K Teruya : Cryptococcosis
3, +* . CD. infected persons©,**,. Recommendations of the U.S.
,**ῌ mL 0 Public Health Service and the Infectious Diseases Society
!"
#$%&'()*+,-./% 01234
of America. MMWR Recomm Rep /+ (RR-2) : +ῌ/,,
5.6789 C :Optional -$, CD. ,**,.
.;<=>?@AB CDEFGH&I
/ Metta HA, Corti ME, Negroni R, et al : Disseminated
23JK.LM$, NOP*(QRSTU)2I
cryptococcosis in patients with AIDS. Clinical, micro-
V/ - WXI2; I2Y CD. 0.*ῌ mL biological, and immunological analysis of /+ patients.
Z++
Rev Argent Microbiol -. : ++1ῌ+,-, ,**,.
0 ª«¬­ ®«¯­ °±²³ ´ : *(QRST*
2 )2µ¶·¸‚¹ \]º ,0 : ,10ῌ,2- +32/.
[\]^ !B_Z$%]`ab,c2
1 van der Horst CM, Saag MS, Cloud GA, et al : Treat-
HAART Xde&fg2hiI2Bjk.lmn
ment of cryptococcal meningitis associated with the ac-
o HAART pqXBDrst.uv22w
quired immunodeficiency syndrome. National Institute
xyB_z{2w|}~/M
of Allergy and Infectious Diseases Mycoses Study Group
*(QRSTU)€‚-ƒY,„…B
HAART pq +* 3" / 3de&fg†‡
and AIDS Clinical Trials Group. N Engl J Med --1 :
+/ῌ,+, +331.
-JK+, , 3ˆ‰EstŠ‹Œ]PD
2 Saag MS, Graybill RJ, Larsen RA, et al : Practice guide-
vI2 + 3Ž(‘’“ + 3”E*(Q
lines for the management of cryptococcal disease. Infec-
RSTU)V•–—H˜ + 3™šBFGH˜†
tious Diseases Society of America. Clin Infect Dis -* :
‡Z - 3B,$›0*(QRSTU)œL
M žŸ 3¡PZ ‡M/ HAART pq
X ,ῌ++ XB†‡Z$,
1+*ῌ1+2, ,***.
3 Kirk O, Reiss P, Uberti-Foppa C, et al : Safe interruption of maintenance therapy against previous infection
Trevenzoli /% ¢P*(QRSTU)2£¤
with four common HIV-associated opportunistic patho-
HAART pqXBI2 *(QRSTU)
gens during potent antiretroviral therapy. Ann Intern
Žv - 3JK$,+- HAART pqX¥¦ 3* §
Med +-1 : ,-3ῌ,/*, ,**,.
IV; :0*ῌ+/* § 3 FLCZ !
+* Vibhagool A, Sungkanuparph S, Mootsikapun P, et al :
Z$, ‚(‘›0B_;
¨M$,
Discontinuation of secondary prophylaxis for crypto-
coccal meningitis in human immunodeficiency virus-
infected patients treated with highly active antiretroviral
+ Kaplan JE, Hanson D, Dworkin MS, et al : Epidemiology of human immunodeficiency virus-associated op-
therapy : a prospective, multicenter, randomized study.
Clin Infect Dis -0 : +-,3ῌ+--+, ,**-.
portunistic infections in the United States in the era of
++ Rambeloarisoa J, Batisse D, Thiebaut JB, et al :
highly active antiretroviral therapy. Clin Infect Dis -*
Intramedullary abscess resulting from disseminated
Suppl + : S/ῌ+., ,***.
cryptococcosis despite immune restoration in a patient
, European
Confederation
of
Medical
Mycology
(ECMM) prospective survey of cryptococcosis : report
from Italy. Med Mycol .* : /*1ῌ/+1, ,**,.
- Mirza SA, Phelan M, Rimland D, et al : The changing
epidemiology of cryptococcosis : an update from population-based active surveillance in , large metropolitan
areas, +33,ῌ,***. Clin Infect Dis -0 : 123ῌ13., ,**-.
. USPHS ; Infectious Disease Society of America : Guidelines for preventing opportunistic infections among HIV-
+2 : +2 with AIDS. J Infect .. : +2/ῌ+22, ,**,.
+, Jenny-Avital ER, Abadi M : Immune reconstitution
cryptococcosis after initiation of successful highly active
antiretroviral therapy. Clin Infect Dis -/ : e+,2ῌ+--,
,**,.
+- Trevenzoli M, Cattelan AM, Rea F, et al : Mediastinitis
due to cryptococcal infection : a new clinical entity in
the HAART era. J Infect ./ : +1-ῌ+13, ,**,.